trending Market Intelligence /marketintelligence/en/news-insights/trending/uuerodcrs-zmnvjyx0xfiq2 content esgSubNav
In This List

Surmodics names interim CFO

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Surmodics names interim CFO

Surmodics Inc. said its CFO would leave the company May 25.

Andrew LaFrence will be replaced by Surmodics' vice president of corporate development and strategy, Timothy Arens, on an interim basis.

LaFrence is leaving the company to join Biothera Pharmaceuticals Inc. as senior vice president and CFO, effective May 29.